A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Clinical trial NCT03817424 · COMPLETED

Trial details

NCT number: NCT03817424
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Cutaneous Lupus Erythematosus Sjogren's Syndrome Systemic Sclerosis Polymyositis Dermatomyositis

Start date: 2018-12-13
Primary completion: 2020-07-20
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.